Sana Biotechnology will cut 15% of its workforce in latest layoffs affecting Seattle companies Seattle-based cell and gene therapy company Sana Biotechnology will reduce its workforce by 15%, according to a statement issued Tuesday.… Read More
Sana Biotechnology to build manufacturing facility in Seattle area, switching from California After announcing plans last summer to build its manufacturing facility in California, Sana Biotechnology has changed course. The cell and… Read More
Juno Therapeutics vets Steve Harr and Hans Bishop on building startups, working with tech, and more Hans Bishop and Steve Harr know a few things about biotech. The pair once worked together at Seattle flagship cell… Read More
Juno’s lasting legacy: How the cell therapy juggernaut influenced biotech in Seattle and beyond When Juno Therapeutics launched in 2013, cell therapy was a nascent field. Early clinical studies were showing dramatic rates of… Read More
Sana CEO reveals details about stealthy gene therapy startup that has raised more than $700M Sana Biotechnology CEO Steve Harr shed more light on one of most secretive, heavily funded startups in Seattle and the… Read More
Former Juno execs unveil Sana, a new cell engineering biotech that’s reportedly raising more than $800M Former Juno Therapeutics executives Hans Bishop and Steve Harr have launched Sana Biotechnology, a startup focused on cell therapy, gene… Read More
